Emergent Biosolutions Inc (NYSE:EBS) has a beta value of 2.16 and has seen 0.89 million shares traded in the recent trading session. The company, currently valued at $266.49M, closed the recent trade at $4.90 per share which meant it gained $0.24 on the day or 5.24% during that session. The EBS stock price is -208.16% off its 52-week high price of $15.10 and 62.86% above the 52-week low of $1.82. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.05 million shares traded. The 3-month trading volume is 1.18 million shares.
The consensus among analysts is that Emergent Biosolutions Inc (EBS) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Emergent Biosolutions Inc (NYSE:EBS) trade information
Sporting 5.24% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the EBS stock price touched $4.90 or saw a rise of 14.49%. Year-to-date, Emergent Biosolutions Inc shares have moved -48.70%, while the 5-day performance has seen it change -14.41%. Over the past 30 days, the shares of Emergent Biosolutions Inc (NYSE:EBS) have changed -34.43%. Short interest in the company has seen 9.16 million shares shorted with days to cover at 5.94.
Wall Street analysts have a consensus price target for the stock at $51.5, which means that the shares’ value could jump 90.49% from the levels at last check today.. The projected low price target is $38.0 while the price target rests at a high of $65.0. In that case, then, we find that the latest price level in today’s session is -1226.53% off the targeted high while a plunge would see the stock gain -675.51% from the levels at last check today..
Emergent Biosolutions Inc (EBS) estimates and forecasts
The company’s shares have lost -32.63% over the past 6 months.
EBS Dividends
Emergent Biosolutions Inc is expected to release its next earnings report on 2025-Mar-02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Emergent Biosolutions Inc (NYSE:EBS)’s Major holders
Insiders own 3.20% of the company shares, while shares held by institutions stand at 64.59% with a share float percentage of 66.72%. Investors are also buoyed by the number of investors in a company, with Emergent Biosolutions Inc having a total of 192.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 3.84 million shares worth more than $26.18 million. As of 2024-06-30, BLACKROCK INC. held 7.2992% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 3.67 million shares as of 2024-06-30. The firm’s total holdings are worth over $25.0 million and represent 7.0234% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are American Century ETF Trust-Avantis U.S. Small Cap Value ETF and SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF . As of Feb 28, 2025 , the former fund manager holds about 3.53% shares in the company for having 1.92 shares of worth $9.11 million while later fund manager owns 1.61 shares of worth $7.64 million as of Nov 30, 2024 , which makes it owner of about 2.96% of company’s outstanding stock.
